Journals / Journal of Urological Surgery / 2021 / Cilt: 8 - Sayı: 3

Management of Urinary Tract Involvement in Placenta Accreta: A Single Institution Experience of 10 Cases

Pages
208–211
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

A multidisciplinary management team is necessary to manage the myriad complications that may arise from PAS.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Placenta accreta spectrum (PAS), which occurs in ~1/500 deliveries, represents the disorders that arise due to adherent placenta, whichmay infiltrate adjacent organs, including the urinary tract.
📊
Key Findings & Data:Recently, its incidence rate has increased because of increasing rate of cesarean deliveriesworldwide.Materials and Methods: Case records of all institutional deliveries that took place at a single, tertiary care hospital within two years were reviewedto identify all patients with PAS.
💡
Conclusion & Impact:A multidisciplinary management team is necessary to manage the myriad complications that may arise from PAS.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Objective: Placenta accreta spectrum (PAS), which occurs in ~1/500 deliveries, represents the disorders that arise due to adherent placenta, whichmay infiltrate adjacent organs, including the urinary tract. Recently, its incidence rate has increased because of increasing rate of cesarean deliveriesworldwide.Materials and Methods: Case records of all institutional deliveries that took place at a single, tertiary care hospital within two years were reviewedto identify all patients with PAS. The case records of patients who required urological referral were studied.Results: In total, 80 patients were diagnosed with PAS. Ten patients (12.5%) required urological referral for urinary tract involvement. All (100%)patients showed bladder involvement. Two patients (2.5%) required ureteric reimplantation. One patient (1.2%) required bilateral ureterostomies asan urgent temporizing measure because the bladder was extensively infiltrated. All patients were discharged in a stable condition. There were nolong-term urological complications observed in patients who followed up (90%).Conclusion: PAS is a condition with high mortality and morbidity rates and increasing incidence. The findings of this study correlate well withinternational series on PAS. A multidisciplinary management team is necessary to manage the myriad complications that may arise from PAS.

🔖

Cite This Article

AKHTAR, O. S., RASOOL, S., MUZAFFAR, U., JABEEN, F. (2021). Management of Urinary Tract Involvement in Placenta Accreta: A Single Institution Experience of 10 Cases. Journal of Urological Surgery, Cilt: 8 - Sayı: 3, 208–211. https://ajindex.com/articles/347506

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Caliskan E, Tan O, Kurtaran V, Dilbaz B, Haberal A. Placenta previa percreta with urinary bladder and ureter invasion. Arch Gynecol Obstet 2003;268:343-344
  2. Wu S, Kocherginsky M, Hibbard JU. Abnormal placentation: twenty-year analysis. Am J Obstet Gynecol 2005;192:1458-1461
  3. Abbas F, Talati J, Wasti S, Akram S, Ghaffar S, Qureshi R. Placenta percreta with bladder invasion as a cause of life threatening hemorrhage. J Urol 2000;164:1270-1274
  4. Pearl ML, Escamilla G, Karpel BM, Kaplan C, Jones C, Westermann C. Conservative management of placenta percreta with involvement of the ileum. Arch Gynecol Obstet 1996;258:147-150
  5. Ng MK, Jack GS, Bolton DM, Lawrentschuk N. Placenta percreta with urinary tract involvement: the case for a multidisciplinary approach. Urology 2009;74:778-782
  6. Silver RM, Landon MB, Rouse DJ, Leveno KJ, Spong CY, Thom EA, Moawad AH, Caritis SN, Harper M, Wapner RJ, Sorokin Y, Miodovnik M, Carpenter M, Peaceman AM, O’Sullivan MJ, Sibai B, Langer O, Thorp JM, Ramin SM, Mercer BM; National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Maternal morbidity associated with multiple repeat cesarean deliveries. Obstet Gynecol 2006;107:1226- 1232
  7. Fitzpatrick KE, Sellers S, Spark P, Kurinczuk JJ, Brocklehurst P, Knight M. Incidence and risk factors for placenta accreta/increta/percreta in the UK: a national case-control study. PLoS One 2012;7:e52893
  8. Washecka R, Behling A. Urologic complications of placenta percreta invading the urinary bladder: a case report and review of the literature. Hawaii Med J 2002;61:66-69
  9. Tam Tam KB, Dozier J, Martin JN Jr. Approaches to reduce urinary tract injury during management of placenta accreta, increta, and percreta: a systematic review. J Matern Fetal Neonatal Med 2012;25:329-334
  10. Norris BL, Everaerts W, Posma E, Murphy DG, Umstad MP, Costello AJ, Wrede CD, Kearsley J. The urologist’s role in multidisciplinary management of placenta percreta. BJU Int 2016;117:961-965
  11. Nieto-Calvache AJ, López-Girón MC, Messa-Bryon A, Ceballos-Posada ML, Duque-Galán M, Ríos-Posada JG, Plazas-Córdoba LA, Chancy-Castaño MM. Urinary tract injuries during treatment of patients with morbidly adherent placenta. J Matern Fetal Neonatal Med 2021;34:3140-3146
  12. Woldu SL, Ordonez MA, Devine PC, Wright JD. Urologic considerations of placenta accreta: a contemporary tertiary care institutional experience. Urol Int 2014;93:74-79
  13. Camuzcuoglu A, Vural M, Hilali NG